As part of its ambition to strengthen regional commercial activities, Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF) has appointed Minja Salmio, currently Chief Legal Officer and a key member of Nightingale Health’s management team, as Chief Commercial Officer for the EMEA region.

Nightingale Health’s commercial operations are structured around three regions: Asia-Pacific (APAC); Europe, the Middle East and Africa (EMEA); and the Americas. The commercial operations in APAC are led by Satu Saksman, while CEO Teemu Suna continues to lead the business in the Americas for the time being. In her new role, Minja Salmio will be responsible for the EMEA region.

“Minja has a broad understanding of the company and as CLO she has already played a key role in our commercial operations. This experience makes her transition into a commercial leadership role a natural progression, especially given our ambition to further expand our commercial activities,” says Teemu Suna, CEO and Founder of Nightingale Health.

In addition to this appointment, Satu Sirén-Lähdeaho, currently Head of Legal, will step into the role of General Counsel. Over her many years at the company, she has been instrumental in the company’s Legal and Compliance function and supporting critical business initiatives.

The new appointments will take effect from 13 June 2025.

Nightingale Health’s Management Team as of 13 June 2025:

• Teemu Suna, CEO, Founder
• Antti Kangas, CTO, Founder
• Satu Saksman, CCO, APAC, Co-founder
• Minja Salmio, CCO, EMEA
• Salla Ruosaari, Chief R&D Officer
• Jeffrey Barrett, CSO
• Tuukka Paavola, CFO
• Janna Ranta, COO